UM Guidelines
Sclerotherapy, Leg Veins

Ambulatory Care (AC)

BCBST last reviewed September 12, 2024*
Changed Clinical Indications include the following:
   
 
  • Leg vein sclerotherapy [for example: liquid, foam or microfoam (Varithena®)]* may be indicated for ALL of the following:.
    • Appropriate clinical condition,
      • Incompetence of saphenous vein as indicated by...
      • Telangiectasias, reticular veins, or tributaries (symptomatic), as indicated by ALL of the following:
        • No untreated underlying saphenous vein insufficiency
        • Symptomatic disease (eg, pain, burning, aching, heaviness, itching, swelling, restless legs)
    • [The treatment is not for telangiectasia (like: spider veins, reticular veins, angiomata)]*
    • ...
   

References

  1. BlueCross BlueShield Association. Evidence Positioning System. (6:2024). Treatment of varicose veins/venous insufficiency. (7.01.124). Retrieved August 14, 2024 from http://www.evidencepositioningsystem.com (63 articles and/or guidelines reviewed)
  2. Geroulakos, G. (2006). Foam Sclerotherapy for the management of varicose veins: a critical reappraisal. Phlebology, 13 (4), 202-206.

 

 

 

Download Acrobat Reader